Polymorphisms in DNA repair and environmental interactions

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 509, Issue 1-2, 2002, Pages 201-210

  De Boer, Johan G ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

DNA repair; Environment; Human; Human health; Individual susceptibility; Polymorphisms

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLINE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; LYASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P21; PROTEIN P27; PROTEIN P53; RAD51 PROTEIN;

ALLELE; CANCER RISK; CELL CYCLE S PHASE; DISEASE PREDISPOSITION; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; DNA STRAND BREAKAGE; ENVIRONMENTAL FACTOR; ENZYME SPECIFICITY; EXCISION REPAIR; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0037202612     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00217-8     Document Type: Article

References (79)

1. Mullaart E., Lohman P.H., Berends F., Vijg J. DNA damage metabolism and aging. Mutat. Res. 237:1990;189-210.
2. Shields P.G., Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 18:2000;2309-2315.
3. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.et al. The sequence of the human genome. Science. 291:2001;1304-1351.
4. Gary R., Park M.S., Nolan J.P., Cornelius H.L., Kozyreva O.G., Tran H.T., Lobachev K.S., Resnick M.A., Gordenin D.A. A novel role in DNA metabolism for the binding of Fen1/Rad27 to PCNA and implications for genetic risk. Mol. Cell Biol. 19:1999;5373-5382.
5. Muller-Koch Y., Kopp R., Lohse P., Baretton G., Stoetzer A., Aust D., Daum J., Kerker B., Gross M., Dietmeier W., Holinski-Feder E. Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: mutations or polymorphisms? Eur. J. Med. Res. 6:2001;473-482.
6. Klaus K., Herfarth F., Ogunbiyi O.A., Moley J.F., Kodner I.J., Wells S.A. Jr., Goodfellow P.J. Four new mutations in the DNA mismatch repair gene MLH1 in colorectal cancers with microsatellite instability. Mutations in brief no. 157, online. Hum. Mutat. 12:1998;73.
7. Kruger S., Plaschke J., Pistorius S., Jeske B., Haas S., Kramer H., Hinterseher I., Bier A., Kreuz F.R., Theissig F., Saeger H.D., Schackert H.K. Seven novel MLH1 and MSH2 germline mutations in hereditary nonpolyposis colorectal cancer. Hum. Mutat. 19:2002;82.
8. Chen Y., Wang J., Fraig M.M., Metcalf J., Turner W.R., Bissada N.K., Watson D.K., Schweinfest C.W. Defects of DNA mismatch repair in human prostate cancer. Cancer Res. 61:2001;4112-4121.
9. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:1991;3075-3079.
10. Parc Y.R., Halling K.C., Wang L., Christensen E.R., Cunningham J.M., French A.J., Burgart L.J., Price-Troska T.L., Roche P.C., Thibodeau S.N. HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res. 60:2000;2225-2231.
11. Akiyama Y., Tsubouchi N., Yuasa Y. Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers. Biochem. Biophys. Res. Commun. 236:1997;248-252.
12. Yuan Z.Q., Gottlieb B., Beitel L.K., Wong N., Gordon P.H., Wang Q., Puisieux A., Foulkes W.D., Trifiro M. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms. Hum. Mutat. 19:2002;108-113.
13. Hosoya N., Hangaishi A., Ogawa S., Miyagawa K., Mitani K., Yazaki Y., Hirai H. Frameshift mutations of the hMSH6 gene in human leukemia cell lines. Jpn. J. Cancer Res. 89:1998;33-39.
14. Lipkin S.M., Wang V., Stoler D.L., Anderson G.R., Kirsch I., Hadley D., Lynch H.T., Collins F.S. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Hum. Mutat. 17:2001;389-396.
15. Lipkin S.M., Wang V., Jacoby R., Banerjee-Basu S., Baxevanis A.D., Lynch H.T., Elliott R.M., Collins F.S. MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat. Gen. 24:2000;27-35.
16. Zhang S., Lloyd R., Bowden G., Glickman B.W., De Boer J.G. Msh2 DNA mismatch repair gene deficiency and the food-borne mutagen 2-amino-1-methy1-6-phenolimidazo [4,5-b] pyridine (PhIP) synergistically affect mutagenesis in mouse colon. Oncogene. 20:2001;6066-6072.
17. Wei Q., Eicher S.A., Guan Y., Cheng L., Xu J., Young L.N., Saunders K.C., Jiang H., Hong W.K., Spitz M.R., Strom S.S. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol. Biomarkers Prev. 7:1998;309-314.
18. Strom S.S., Spitz M.R., Yamamura Y., Babaian R.J., Scardino P.T., Wei Q. Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study. Prostate. 47:2001;269-275.
19. Cheng L., Eicher S.A., Guo Z., Hong W.K., Spitz M.R., Wei Q. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev. 7:1998;465-468.
20. Butkiewicz D., Rusin M., Harris C.C., Chorazy M. Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population. Hum. Mutat. 15:2000;577-578.
21. Emmert S., Schneider T.D., Khan S.G., Kraemer K.H. The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms. Nucleic Acids Res. 29:2001;1443-1452.
22. Hemminki K., Xu G., Angelini S., Snellman E., Jansen C.T., Lambert B., Hou S.M. XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ. Carcinogenesis. 22:2001;1185-1188.
23. Palli D., Russo A., Masala G., Saieva C., Guarrera S., Carturan S., Munnia A., Matullo G., Peluso M. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int. J. Cancer. 94:2001;121-127.
24. Khan S.G., Metter E.J., Tarone R.E., Bohr V.A., Grossman L., Hedayati M., Bale S.J., Emmert S., Kraemer K.H. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis. 21:2000;1821-1825.
25. Chavanne F., Broughton B.C., Pietra D., Nardo T., Browitt A., Lehmann A.R., Stefanini M. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res. 60:2000;1974-1982.
26. Gozukara E.M., Khan S.G., Metin A., Emmert S., Busch D.B., Shahlavi T., Coleman D.M., Miller M., Chinsomboon N., Stefanini M., Kraemer K.H. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. J. Invest Dermatol. 117:2001;197-204.
27. Yu Y., Okayasu R., Weil M.M., Silver A., McCarthy M., Zabriskie R., Long S., Cox R., Ullrich R.L. Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene. Cancer Res. 61:2001;1820-1824.
28. Severin D.M., Leong T., Cassidy B., Elsaleh H., Peters L., Venter D., Southey M., McKay M. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 50:2001;1323-1331.
29. Livak K.J., Little W.A., Stack S.L., Patterson T.A. Polymorphisms in the human DNA ligase I gene (LIG1) including a complex GT repeat. Mutat. Res. 406:1998;1-8.
30. Riballo E., Critchlow S.E., Teo S.H., Doherty A.J., Priestley A., Broughton B., Kysela B., Beamish H., Plowman N., Arlett C.F., Lehmann A.R., Jackson S.P., Jeggo P.A. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr. Biol. 9:1999;699-702.
31. O'Driscoll M., Cerosaletti K.M., Girard P.M., Dai Y., Stumm M., Kysela B., Hirsch B., Gennery A., Palmer S.E., Seidel J., Gatti R.A., Varon R., Oettinger M.A., Neitzel H., Jeggo P.A., Concannon P. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell. 8:2001;1175-1185.
32. Barnes D.E., Tomkinson A.E., Lehmann A.R., Webster A.D., Lindahl T. Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell. 69:1992;495-503.
33. Price E.A., Bourne S.L., Radbourne R., Lawton P.A., Lamerdin J., Thompson L.H., Arrand J.E. Rare microsatellite polymorphisms in the DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somat. Cell Mol. Gen. 23:1997;237-247.
34. Harris G., Cramp W.A., Edwards J.C., George A.M., Sabovljev S.A., Hart L., Hughes G.R., Denman A.M., Yatvin M.B. Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int. J. Radiat. Biol. Relat Stud. Phys. Chem. Med. 47:1985;689-699.
35. McCurdy D., Tai L.Q., Frias S., Wang Z. Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis. Radiat. Res. 147:1997;48-54.
36. Chatterjee S., Berger N.A. X-ray-induced damage repair in exponentially growing and growth arrested confluent poly(adenosine diphosphate-ribose) polymerase-deficient V79 chinese hamster cell line. Int. J. Oncol. 17:2000;955-962.
37. Moynahan M.E., Chiu J.W., Koller B.H., Jasin M. Brca1 controls homology-directed DNA repair. Mol. Cell. 4:1999;511-518.
38. Moynahan M.E., Pierce A.J., Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell. 7:2001;263-272.
39. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Gen. 30:2002;285-289.
40. Ozdag H., Tez M., Sayek I., Muslumanoglu M., Tarcan O., Icli F., Ozturk M., Ozcelik T. Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients. Eur. J. Cancer. 36:2000;2076-2082.
41. Steinmann D., Bremer M., Rades D., Skawran B., Siebrands C., Karstens J.H., Dork T. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Br. J. Cancer. 85:2001;850-858.
42. Armakolas A., Ladopoulou A., Konstantopoulou I., Pararas B., Gomatos I.P., Kataki A., Konstadoulakis M.M., Stathopoulos G.P., Markopoulos C., Leandros E., Gogas I., Yannoukakos D., Androulakis G. BRCA2 gene mutations in Greek patients with familial breast cancer. Hum. Mutat. 19:2002;81-82.
43. Baudi F., Quaresima B., Grandinetti C., Cuda G., Faniello C., Tassone P., Barbieri V., Bisegna R., Ricevuto E., Conforti S., Viel A., Marchetti P., Ficorella C., Radice P., Costanzo F., Venuta S. Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum. Mutat. 18:2001;163-164.
44. Wang W.W., Spurdle A.B., Kolachana P., Bove B., Modan B., Ebbers S.M., Suthers G., Tucker M.A., Kaufman D.J., Doody M.M., Tarone R.E., Daly M., Levavi H., Pierce H., Chetrit A., Yechezkel G.H., Chenevix-Trench G., Offit K., Godwin A.K., Struewing J.P. A single nucleotide polymorphism in the 5′' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol. Biomarkers Prev. 10:2001;955-960.
45. Levy-Lahad E., Lahad A., Eisenberg S., Dagan E., Paperna T., Kasinetz L., Catane R., Kaufman B., Beller U., Renbaum P., Gershoni-Baruch R. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3232-3236.
46. Girard P.M., Foray N., Stumm M., Waugh A., Riballo E., Maser R.S., Phillips W.P., Petrini J., Arlett C.F., Jeggo P.A. Radiosensitivity in Nijmegen Breakage Syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects. Cancer Res. 60:2000;4881-4888.
47. Varon R., Reis A., Henze G., von Einsiedel H.G., Sperling K., Seeger K. Mutations in the Nijmegen Breakage Syndrome gene (Nbs1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res. 61:2001;3570-3572.
48. Abdel-Rahman S.Z., El Zein R.A. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 159:2000;63-71.
49. Ratnasinghe D., Yao S.X., Tangrea J.A., Qiao Y.L., Andersen M.R., Barrett M.J., Giffen C.A., Erozan Y., Tockman M.S., Taylor P.R. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 10:2001;119-123.
50. Lee J.M., Lee Y.C., Yang S.Y., Yang P.W., Luh S.P., Lee C.J., Chen C.J., Wu M.T. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int. J. Cancer. 95:2001;240-246.
51. Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E., Krogh V., Munnia A., Tumino R., Polidoro S., Piazza A., Vineis P. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 22:2001;1437-1445.
52. Paunesku T., Mittal S., Protic M., Oryhon J., Korolev S.V., Joachimiak A., Woloschak G.E. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int. J. Radiat. Biol. 77:2001;1007-1021.
53. Miura M. Detection of chromatin-bound PCNA in mammalian cells and its use to study DNA excision repair. J. Radiat. Res.(Tokyo). 40:1999;1-12.
54. Jin Y.H., Obert R., Burgers P.M., Kunkel T.A., Resnick M.A., Gordenin D.A. The 3′ - >5′ exonuclease of DNA polymerase delta can substitute for the 5′ flap endonuclease Rad27/Fen1 in processing Okazaki fragments and preventing genome instability. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5122-5127.
55. Ma X., Jin Q., Forsti A., Hemminki K., Kumar R. Single nucleotide polymorphism analyses of the human proliferating cell nuclear antigen (pCNA) and flap endonuclease (FEN1) genes. Int. J. Cancer. 88:2000;938-942.
56. Ishida T., Takashima R., Fukayama M., Hamada C., Hippo Y., Fujii T., Moriyama S., Matsuba C., Nakahori Y., Morita H., Yazaki Y., Kodama T., Nishimura S., Aburatani H. New DNA polymorphisms of human MMH/OGG1 gene: prevalence of one polymorphism among lung-adenocarcinoma patients in Japanese. Int. J. Cancer. 80:1999;18-21.
57. Pieretti M., Khattar N.H., Smith S.A. Common polymorphisms and somatic mutations in human base excision repair genes in ovarian and endometrial cancers. Mutat. Res. 432:2001;53-59.
58. Hyun J.W., Cheon G.J., Kim H.S., Lee Y.S., Choi E.Y., Yoon B.H., Kim J.S., Chung M.H. Radiation sensitivity depends on OGG1 activity status in human leukemia cell lines. Free Radic. Biol. Med. 32:2002;212-220.
59. Herring C.J., West C.M., Wilks D.P., Davidson S.E., Hunter R.D., Berry P., Forster G., MacKinnon J., Rafferty J.A., Elder R.H., Hendry J.H., Margison G.P. Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br. J. Cancer. 78:1998;1128-1133.
60. Herring C.J., Deans B., Elder R.H., Rafferty J.A., MacKinnon J., Barzilay G., Hickson I.D., Hendry J.H., Margison G.P. Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines. Br. J. Cancer. 80:1999;940-945.
61. Hadi M.Z., Coleman M.A., Fidelis K., Mohrenweiser H.W., Wilson D.M. III Functional characterization of Ape1 variants identified in the human population. Nucl. Acids Res. 28:2000;3871-3879.
62. Hu J.J., Smith T.R., Miller M.S., Mohrenweiser H.W., Golden A., Case L.D. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 22:2001;917-922.
63. Hayward C., Colville S., Swingler R.J., Brock D.J. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology. 52:1999;1899-1901.
64. 6-alkylguanine-DNA alkyltransferase. Science. 259:1993;219-222.
65. 6-alky lguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res. 50:1990;6119-6129.
66. Vahakangas K., Trivers G.E., Plummer S., Hayes R.B., Krokan H., Rowe M. O-6-Methylguanine-DNA methyltransferase and uracil DNA glycosylase in human broncho-alveolar lavage cells and peripheral blood mononuclear cells from tobacco smokers and non-smokers. Carcinogenesis. 12:1991;1389-1394.
67. 6-methylguanine-DNA methyltransferase gene in young patients with adult type cancers and functional assay. Carcinogenesis. 16:1995;2441-2445.
68. 6-methylguanine-DNA methyltransferase gene detected by PCR-SSCP analysis. Pharmacogenetics. 6:1996;361-363.
69. 6-alkylguanine-DNA alkyltransferase: identification of a missense variation in the active site region. Pharmacogenetics. 9:1999;81-87.
70. 6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 9:2000;339-342.
71. 6-benzylguanine. Cancer Res. 56:1996;5571-5575.
72. 6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer. Clin. Cancer Res. 5:1999;209-213.
73. Belanich M., Pastor M., Randall T., Guerra D., Kibitel J., Alas L., Li B., Citron M., Wasserman P., White A., Eyre H., Jaeckle K., Schulman S., Rector D., Prados M., Coons S., Shapiro W., Yarosh D. Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res. 56:1996;783-788.
74. 6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J. Neurosurg. 70:1989;573-577.
75. 6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br. J. Cancer. 67:1993;1299-1302.
76. Smith M.L., Ford J.M., Hollander M.C., Bortnick R.A., Amundson S.A., Seo Y.R., Deng C.X., Hanawalt P.C., Fornace A.J. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol. Cell Biol. 20:2000;3705-3714.
77. Hanawalt P.C. Role of transcription-coupled DNA repair in susceptibility to environmental carcinogenesis. Environ. Health Perspect. 104(Suppl 3):1996;547-551.
78. Blaszyk H., Hartmann A., Sommer S.S., Kovach J.S. A polymorphism but no mutations in the GADD45 gene in breast cancers. Hum. Gen. 97:1996;543-547.
79. Buettner V.L., Nishino H., Haavik J., Knoll A., Hill K., Sommer S.S. Spontaneous mutation frequencies and spectra in p53 (+/+) and p53 (-/-) mice: a test of the 'guardian of the genome' hypothesis in the Big Blue transgenic mouse mutation detection system. Mutat. Res. 379:1997;13-20.